noom glp-1 cost Med Noom Launches Microdose GLP-1 Program,

Although we focused on non-diabetic individuals with overweight and obesity, potential confounding factors such as concomitant medications, baseline gastrointestinal conditions, and varying lifestyle factors could have influenced the incidence and severity of reported adverse events

Gilbert, Rosenthal, March 2024)

Whilst both berberine and GLP-1 agonists may influence glucose metabolism and body weight, they achieve these effects through entirely different pharmacological pathways

Larson JM, Tavakkoli A, Drane WE, Toskes PP, Moshiree B

Use a reliable scale and measure your height carefully

The costs involved with off-label prescribing may be subject to higher variance